Astrazeneca plc ADR [AZN] stock is trading at $72.60, down -1.22%. An important factor to consider is whether the stock is rising or falling in short-term value. The AZN shares have lost -0.62% over the last week, with a monthly amount drifted -4.60%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Astrazeneca plc ADR [NASDAQ: AZN] stock has seen the most recent analyst activity on February 13, 2025, when UBS upgraded its rating to a Buy. On November 20, 2024, upgrade upgraded it’s rating to Neutral. Deutsche Bank upgraded its rating to a Hold. Deutsche Bank downgraded its rating to a Sell. Goldman started tracking with a Buy rating for this stock on May 30, 2024, and assigned it a price target of $97. In a note dated April 16, 2024, Deutsche Bank upgraded an Hold rating on this stock.
Astrazeneca plc ADR [AZN] stock has fluctuated between $62.75 and $87.68 over the past year. Currently, Wall Street analysts expect the stock to reach $88 within the next 12 months. Astrazeneca plc ADR [NASDAQ: AZN] shares were valued at $72.60 at the most recent close of the market. An investor can expect a potential return of 21.21% based on the average AZN price forecast.
Analyzing the AZN fundamentals
Astrazeneca plc ADR [NASDAQ:AZN] reported sales of 54.07B for the trailing twelve months, which represents a growth of 23.84%. Gross Profit Margin for this corporation currently stands at 0.81% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.16%, and Net Profit Margin reading is 0.13%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.18 and Total Capital is 0.13. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.74.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 72.01 points at the first support level, and at 71.42 for the second support level. However, for the 1st resistance point, the stock is sitting at 73.60, and for the 2nd resistance point, it is at 74.60.
Ratios To Look Out For
For context, Astrazeneca plc ADR’s Current Ratio is 0.93. On the other hand, the Quick Ratio is 0.74, and the Cash Ratio is 0.2. Considering the valuation of this stock, the price to sales ratio is 4.16, the price to book ratio is 5.52 and price to earnings (TTM) ratio is 32.22.
